Buy One Get One free -Llimited Time Offer X
Emletra Tablet (10) is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Emletra Tablet (10) have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Emletra Tablet (10). The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Emletra Tablet (10) include Headache. While these are the most often observed Emletra Tablet (10) side effects, there are can be others also. These have been listed below. These side effects of Emletra Tablet (10) are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Emletra Tablet (10)'s effect is Moderate during pregnancy and Moderate for lactating mothers. Further, the section on Emletra Tablet (10) related warnings talks about Emletra Tablet (10)'s effects on the liver, heart and kidney.
Emletra Tablet (10) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Emletra Tablet (10) in conditions like Liver Disease, Hemophilia. The section on Emletra Tablet (10) contraindications lists all such conditions.
Additionally, Emletra Tablet (10) may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Emletra Tablet (10), it is important to know that it is not safe while driving, and is not habit-forming.
Emletra Tablet (10) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Emletra Tablet (10) safe for pregnant women?
Emletra may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Emletra again without your doctor's advice.
Is the use of Emletra Tablet (10) safe during breastfeeding?
Emletra can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Emletra Tablet (10) on the Kidneys?
There are no side effects of Emletra on the kidneys.
What is the effect of Emletra Tablet (10) on the Liver?
Very few cases of side effects of Emletra on the liver have been reported.
What is the effect of Emletra Tablet (10) on the Heart?
Emletra has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Emletra Tablet (10) unless your doctor advises you to do so -
Is this Emletra Tablet (10) habit forming or addictive?
Emletra Tablet (10) does not cause addiction.
Interaction between Food and Emletra Tablet (10)
Eating certain foods may increase the time it takes Emletra Tablet (10) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Emletra Tablet (10)
Taking alcohol with Emletra Tablet (10) can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvir (ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 810
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 939-941
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Kaletra (lopinavir and ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 811